Pcn302 - Is the New Nice Appraisal Process for Oncology Indications Too Positive in Its Assessment of Cancer Drugs in England?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.384
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn288 - Has the New Nice Appraisal Process for Oncology Drugs Delivered Faster Patient Access to Innovative Treatments?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php279 - Assessment of the Nice Fast-Track Appraisal (Fta) Process

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn230 - Are Nice and the SMC Diverging in Their Assessment of Oncology Drugs?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn239 - Nice and the Cancer Drugs Fund: Appraising Treatments for Rarer Cancers in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn305 - Nice and the Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions in Oncology?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmd171 - Health Technology Assessment of Companion Diagnostics Alongside Therapeutc Agents in Oncology: Experience of the Nice Technology Appraisal Programme

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Evidence That Werewolves Affect the Nice Appraisal Process

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

When the Outcome of an Appraisal Is Not Nice: A Review of Nice Appeals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN Guidelines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy